Session 2 Panel Discussion

Video Overview

SRF CEO Mike Kope moderated the panel discussion concluding our second session, joined by speakers Brian Kennedy, Debra Miller and Brocke Reeve. The panel considered the social and political challenges that continue to block significant increases in public funding for rejuvenation biotechnology, particularly an excessive degree of risk aversion that has largely excluded projects perceived as “ambitious” from consideration by bodies such as NIH – as well as the problematic short-termism sometimes demonstrated by large corporate investors.